BIMI International Medical Inc. (BIMI)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | -8.40 USD | 99.75% |
| 2021 | -3256.11 USD | -18254.62% |
| 2020 | -17.74 USD | 25.59% |
| 2019 | -23.84 USD | 78.76% |
| 2018 | -112.25 USD | -911.26% |
| 2017 | -11.10 USD | 20.71% |
| 2016 | -14.00 USD | -80.88% |
| 2015 | -7.74 USD | -40.73% |
| 2014 | -5.50 USD | -235.37% |
| 2013 | -1.64 USD | -264.0% |
| 2012 | 1.00 USD | -94.74% |
| 2011 | 19.00 USD | -53.09% |
| 2010 | 40.50 USD | -10.0% |
| 2009 | 45.00 USD | 33.33% |
| 2008 | 33.75 USD | 50.0% |
| 2007 | 22.50 USD | -70.0% |
| 2006 | 75.00 USD | 120.98% |
| 2005 | -357.44 USD | -973.07% |
| 2004 | -33.31 USD | -17.91% |
| 2003 | -28.25 USD | 90.68% |
| 2002 | -303.09 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q1 | -0.23 USD | 94.44% |
| 2023 Q2 | 0.23 USD | 200.0% |
| 2023 Q3 | -0.49 USD | -313.04% |
| 2022 Q4 | -4.14 USD | -158.75% |
| 2022 FY | - USD | 99.75% |
| 2022 Q3 | -1.60 USD | -131.88% |
| 2022 Q1 | -2.72 USD | 95.03% |
| 2022 Q2 | -0.69 USD | 74.63% |
| 2021 Q2 | -0.58 USD | 94.19% |
| 2021 Q1 | -9.98 USD | -31.49% |
| 2021 FY | - USD | -18254.62% |
| 2021 Q3 | -3.14 USD | -441.38% |
| 2021 Q4 | -54.78 USD | -1644.59% |
| 2020 Q1 | -11.84 USD | 12.94% |
| 2020 Q3 | -9.09 USD | -138.68% |
| 2020 Q4 | -7.59 USD | 16.5% |
| 2020 FY | - USD | 25.59% |
| 2020 Q2 | 23.50 USD | 298.48% |
| 2019 Q1 | -3.75 USD | 96.1% |
| 2019 FY | - USD | 78.76% |
| 2019 Q4 | -13.60 USD | -303.56% |
| 2019 Q3 | -3.37 USD | 38.73% |
| 2019 Q2 | -5.50 USD | -46.67% |
| 2018 FY | - USD | -911.26% |
| 2018 Q1 | -3.48 USD | -5.78% |
| 2018 Q2 | -10.89 USD | -212.93% |
| 2018 Q3 | -2.05 USD | 81.18% |
| 2018 Q4 | -96.22 USD | -4593.66% |
| 2017 FY | - USD | 20.71% |
| 2017 Q2 | -1.85 USD | 38.33% |
| 2017 Q1 | -3.00 USD | 31.19% |
| 2017 Q3 | -2.96 USD | -60.0% |
| 2017 Q4 | -3.29 USD | -11.15% |
| 2016 Q2 | -2.11 USD | 49.03% |
| 2016 FY | - USD | -80.88% |
| 2016 Q1 | -4.14 USD | 28.25% |
| 2016 Q4 | -4.36 USD | -45.33% |
| 2016 Q3 | -3.00 USD | -42.18% |
| 2015 Q1 | -0.75 USD | 81.39% |
| 2015 Q3 | -0.05 USD | 94.54% |
| 2015 FY | - USD | -40.73% |
| 2015 Q4 | -5.77 USD | -10911.45% |
| 2015 Q2 | -0.96 USD | -28.0% |
| 2014 Q1 | -1.00 USD | 48.19% |
| 2014 FY | - USD | -235.37% |
| 2014 Q2 | -3.32 USD | -232.0% |
| 2014 Q4 | -4.03 USD | -234.33% |
| 2014 Q3 | 3.00 USD | 190.36% |
| 2013 Q2 | 0.50 USD | 450.66% |
| 2013 Q3 | -0.23 USD | -146.0% |
| 2013 Q4 | -1.93 USD | -739.13% |
| 2013 Q1 | 0.09 USD | -85.59% |
| 2013 FY | - USD | -264.0% |
| 2012 Q3 | 0.01 USD | -94.53% |
| 2012 FY | - USD | -94.74% |
| 2012 Q4 | 0.63 USD | 6674.19% |
| 2012 Q1 | 0.00 USD | -99.99% |
| 2012 Q2 | 0.17 USD | 16900.0% |
| 2011 Q3 | 0.50 USD | -88.89% |
| 2011 Q1 | 2.50 USD | -44.93% |
| 2011 FY | - USD | -53.09% |
| 2011 Q4 | 10.86 USD | 2072.0% |
| 2011 Q2 | 4.50 USD | 80.0% |
| 2010 FY | - USD | -10.0% |
| 2010 Q1 | 3.50 USD | -71.98% |
| 2010 Q2 | 13.00 USD | 271.43% |
| 2010 Q3 | 19.50 USD | 50.0% |
| 2010 Q4 | 4.54 USD | -76.72% |
| 2009 Q1 | 3.75 USD | -59.15% |
| 2009 Q2 | 7.50 USD | 100.0% |
| 2009 Q3 | 20.50 USD | 173.33% |
| 2009 Q4 | 12.49 USD | -39.07% |
| 2009 FY | - USD | 33.33% |
| 2008 Q1 | 7.50 USD | -9.42% |
| 2008 Q4 | 9.18 USD | -18.4% |
| 2008 Q3 | 11.25 USD | 0.0% |
| 2008 Q2 | 11.25 USD | 50.0% |
| 2008 FY | - USD | 50.0% |
| 2007 Q4 | 8.28 USD | 10.4% |
| 2007 Q2 | 11.25 USD | 1259.79% |
| 2007 Q1 | -0.97 USD | -106.92% |
| 2007 FY | - USD | -70.0% |
| 2007 Q3 | 7.50 USD | -33.33% |
| 2006 Q2 | -7.00 USD | 23.66% |
| 2006 Q3 | -20.29 USD | -189.86% |
| 2006 Q4 | 14.02 USD | 169.1% |
| 2006 FY | - USD | 120.98% |
| 2006 Q1 | -9.17 USD | 82.36% |
| 2005 Q4 | -51.99 USD | 56.03% |
| 2005 FY | - USD | -973.07% |
| 2005 Q3 | -118.25 USD | -25.36% |
| 2005 Q1 | -92.77 USD | 6.72% |
| 2005 Q2 | -94.33 USD | -1.68% |
| 2004 Q3 | -9.72 USD | -19.56% |
| 2004 Q1 | -5.62 USD | 94.2% |
| 2004 Q2 | -8.13 USD | -44.66% |
| 2004 FY | - USD | -17.91% |
| 2004 Q4 | -99.45 USD | -923.15% |
| 2003 FY | - USD | 90.68% |
| 2003 Q4 | -96.96 USD | -1949.89% |
| 2003 Q3 | -4.73 USD | 51.54% |
| 2003 Q1 | -4.96 USD | 95.3% |
| 2003 Q2 | -9.76 USD | -96.77% |
| 2002 Q2 | -64.29 USD | 23.67% |
| 2002 FY | - USD | 0.0% |
| 2002 Q3 | -50.34 USD | 21.7% |
| 2002 Q1 | -84.23 USD | 0.0% |
| 2002 Q4 | -105.42 USD | -109.42% |
| Name | Eps | Eps Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -52.60 USD | 84.03% |
| China Jo-Jo Drugstores, Inc. | -2.93 USD | -186.689% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | -0.75 USD | -1020.0% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | -0.75 USD | -1020.0% |
| Leafly Holdings, Inc. | -4.74 USD | -77.215% |
| Leafly Holdings, Inc. | -4.74 USD | -77.215% |
| LifeMD, Inc. | -0.70 USD | -1100.0% |
| LifeMD, Inc. | -0.70 USD | -1100.0% |
| TRxADE HEALTH, Inc. | -23.35 USD | 64.026% |
| PetMed Express, Inc. | -0.37 USD | -2170.27% |
| Walgreens Boots Alliance, Inc. | -10.01 USD | 16.084% |